Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study

Okucu, Emrah; Yucetas, Ugur; Karsiyakali, Nejdet; Koseoglu, Hikmet; Yucetas, Esma; Erkan, Erkan; Kadihasanoglu, Mustafa; Toktas, Mahmut Gokhan

doi:10.56434/j.arch.esp.urol.20237602.14

Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study

Date

2023

Authors

Kadihasanoglu, Mustafa

Toktas, Mahmut Gokhan

dc.identifier.doi

10.56434/j.arch.esp.urol.20237602.14

dc.identifier.other

WOS:000986818100001

Publisher

INIESTARES, S.A.

DOI

10.56434/j.arch.esp.urol.20237602.14

Keywords

bladder cancer , endocan , ESM\\-1 , non\\-muscle\\-invasive bladder cancer , muscle\\-invasive bladder cancer , tumor marker

URI

https://openaccess.acibadem.edu.tr/handle/11443/6543

Collections

WOS

Full item page

Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By